◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksB › BLWV-M

Blue Wave Water Capital Ltd (BLWV-M) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-19

Blue Wave Water Capital Ltd (BLWV-M) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tel Aviv-Yafo, Israel with about 2 employees. Its market capitalization is roughly ₪11 million. In the fiscal year ended 2025-12-31, BLWV-M reported ₪0M in revenue and (₪2M) in net income.

Blue Wave Water Capital Ltd engages in the multiplication, cultivation, production, and sale of cannabis for medical purposes in Israel and internationally. Blue Wave Water Capital Ltd was formerly known as Pharmocann Global Ltd and changed its name to Blue Wave Water Capital Ltd in February 2025.

Interactive charts & full statements →

BLWV-M Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue₪0M₪0M₪0M₪0M
Gross Profit₪0M₪0M(₪0M)(₪0M)
Operating Income (EBIT)(₪2M)(₪2M)(₪2M)(₪2M)
Net Income(₪2M)(₪3M)(₪10M)(₪24M)

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

BLWV-M Free Cash Flow History

BLWV-M Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets₪2M₪2M₪7M₪18M
Total Liabilities₪2M₪2M₪6M₪10M

ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLWV-M viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

This page in other languages: עברית

← BLWAll “B” companiesBLX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.